Biodexa Pharmaceuticals Plc
BDRX · NASDAQ
Market closed$2.13$0.00 (0.00%)After hours $2.10 · -1.25%
Key statistics
Previous close$2.13
Open$2.06
Day high$2.16
Day low$2.02
52-week high$59.40
52-week low$2.02
Market cap1.59M
Volume31.19K
Average volume400.88K
P/E ratio-2.54K
Forward P/E—
EPS0.00
Dividend yield0.00%
Market context
Why it moved
BDRX saw no significant price movement today, trading flat with minimal volume as no major company-specific news or catalysts emerged to drive directional momentum.
What is happening
Recent company-specific developments and publisher coverage.
Stock Titan · June 30, 2026Biodexa secures $3.5M with ADS sale and warrant packageInvesting.com · April 2, 2026Biodexa partners with Syngene for MTX240 manufacturingYahoo Finance UK · April 2, 2026Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial SuppliesBusiness Wire · March 31, 2026Tanner Pharma Group and Biodexa Launch Global Early Access Program for FAP PatientsQuiver Quantitative · January 5, 2026Biodexa Pharmaceuticals PLC Appoints Fiona Sharp as Chief Financial Officer and Company SecretaryStocktwits · July 3, 2025Biodexa Stock Surges On FDA's Fast-Track Tag For Treatment Of Cancer-Causing Condition: Retail Confidence Peaks Mt Newswire · June 29, 2026Biodexa Pharmaceuticals Says Health Canada Approves Expansion of Phase 3 Familial Adenomatous Polyposis Trial